BTG Competitors and Similar CompaniesClear all
Zogenix's competitors and similar companies include Durect and Paion.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | |
Founding Date | Founding Date 2006 | Founding Date N/A | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Cupertino, US HQ | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB |
Employees | Employees 743% increase | Employees 902% increase | Employees 3218% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 45.3 m | Valuation ($) 49.7 m |
Financial | |||
Revenue (est.) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) €33.2m (FY, 2022) |
Cost of goods | Cost of goods $4.8m (FY, 2021) | Cost of goods $78k (FY, 2024) | Cost of goods €382k (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit $2m (FY, 2024) | Gross profit €33.4m (FY, 2022) |
Net income | Net income ($227.4m) (FY, 2021) | Net income ($8.3m) (FY, 2024) | Net income (€579k) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 20m | Total funding raised $ 15.2m |
For sources of this data, please see the company profile
View Company Profiles
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View companyPaion
HQ
Aachen, DE
Employees
32↓ 18% decrease
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company